Peptides CAS 121062-08-6 Mt-2/158861-67-5 129954- 34 -3 218949-48-5 34973-08-5 32780-32-8 86168-78-7 189691-06-3 77591-33-4 804475-66-9 61489-71-2

China Peptides CAS 121062-08-6 Mt-2/158861-67-5 129954-34-3 218949-48-5 34973-08-5 32780-32-8 86168-78-7 189691-06-3 77591-33-4 804475-66-9 61489-71-2, Find details about China Mt-2, 158861-67-5 from Peptides CAS 121062-08-6 Mt-2/158861-67-5 129954-34-3 218949-48-5 34973-08-5 32780-32-8 86168-78-7 189691-06-3 77591-33-4 804475-66-9 61489-71-2

Model NO.
121062-08-6
Model No
121062-08-6
Certificate
GMP ISO USP Bp
Test
HPLC
Grade Standard
Food Grade, Medicine Grade
Type of Product
Auxiliaries and Other Medicinal Chemicals
Shelf Life
2 Years Proper Storage
Product Name
Vonoprazan Fumarate
Assay
99%Min, 98.0% --101.0%
Sample
Vonoprazan Fumarate Valiable
Appearance
White Powder
Storage
Cool Dry Place
Mf
C21h20fn3o6s
Trademark
QDAmgen
Transport Package
Cardboard Barrel
Specification
25KG
Origin
China
Model NO.
121062-08-6
Model No
121062-08-6
Certificate
GMP ISO USP Bp
Test
HPLC
Grade Standard
Food Grade, Medicine Grade
Type of Product
Auxiliaries and Other Medicinal Chemicals
Shelf Life
2 Years Proper Storage
Product Name
Vonoprazan Fumarate
Assay
99%Min, 98.0% --101.0%
Sample
Vonoprazan Fumarate Valiable
Appearance
White Powder
Storage
Cool Dry Place
Mf
C21h20fn3o6s
Trademark
QDAmgen
Transport Package
Cardboard Barrel
Specification
25KG
Origin
China
Peptides CAS 121062-08-6 Mt-2/158861-67-5 129954-34-3 218949-48-5 34973-08-5 32780-32-8 86168-78-7 189691-06-3 77591-33-4 804475-66-9 61489-71-2Peptides CAS 121062-08-6 Mt-2/158861-67-5 129954-34-3 218949-48-5 34973-08-5 32780-32-8 86168-78-7 189691-06-3 77591-33-4 804475-66-9 61489-71-2

What is Vonoprazan Fumarate ?

Vonoprazan fumarate is a first-in-class potassium-competitive acid blocker.

Fuction and Application of Vonoprazan Fumarate

     Vonoprazan can be used for the treatment of gastroduodenal ulcer (including some drug-induced peptic ulcers) and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori.

      Vonoprazan fumarate shows strong and sustainable acid secretion inhibitory effects as well as demonstrate efficacy in early termination by inhibiting the binding of potassium ion (K+) to H+, K+-ATPase (proton pump) in the final step of gastric acid secretion in gastric parietal cells.